Jun 2026 (Q2 FY26) — Aug 6, 2026
Evolent Health Q2 FY26 — Strong Performance Suite Growth and Raised Full-Year Guidance
Read the full callEvolent Health (EVH) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Evolent Health earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 653 | +46.9% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -1.5 | −1.2 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -28.4 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$4.87 +2.96% · +$0.14
Performance −36.8% 1Y
1Y: $7.71 on 14 Oct 2025 → $4.87. High $8.18 (21 Oct 2025), low $2.17 (30 Mar 2026).
- Previous close
- $4.73
- 52-week range
- $2.17 – $8.18
- One year
- −37.88%
Overview
- Symbol
- EVH
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Evolent Health earnings calls (EVH)
Financials
What the filings say
Net profit, year on year: −43% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 621 | 647 | 484 | 444 | 480 | 469 | 496 | 653 |
| Expenses | 638 | 665 | 485 | 445 | 479 | 877 | 507 | 662 |
| Operating profit | -16 | -19 | -2 | -1 | 1 | -408 | -11 | -10 |
| Operating margin | −2.6% | −2.9% | −0.3% | −0.3% | 0.2% | −87.1% | −2.1% | −1.5% |
| Interest | 6 | 7 | 10 | 12 | 16 | 19 | 17 | 17 |
| Profit before tax | -24 | -24 | -63 | -21 | -20 | -431 | -26 | -26 |
| Tax rate | 2.6% | 4.7% | −2.3% | 4.0% | −4.5% | 0.4% | −3.5% | −10.6% |
| Net profit | -23 | -23 | -65 | -20 | -21 | -429 | -27 | -28 |
| EPS ($ per share) | -0.27 | -0.27 | -0.63 | -0.44 | -0.24 | -3.84 | -0.24 | -0.25 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | — | — | 1 | 1 | 1 | 1 | 1 | 1 |
| Reserves | 50 | -252 | -589 | -627 | -606 | -719 | -781 | -1,315 |
| Total liabilities | 533 | 569 | 752 | 726 | 958 | 1,434 | 1,353 | 1,484 |
| Fixed assets | 74 | 85 | 86 | 81 | 88 | 78 | 73 | 81 |
| Total assets | 1,722 | 1,498 | 1,372 | 1,419 | 1,817 | 2,680 | 2,544 | 1,899 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -21 | -43 | -16 | 39 | -12 | 143 | 19 | 39 |
| Cash from investing | -160 | -182 | 261 | -16 | -259 | -416 | -63 | -0 |
| Cash from financing | 274 | -36 | -12 | -30 | 132 | 281 | -1 | -36 |
| Net cash flow | 93 | -260 | 233 | -7 | -140 | 8 | -45 | 2 |
| Capital expenditure | -40 | -36 | — | — | — | — | — | — |
| Free cash flow | -60 | -78 | — | — | — | — | — | — |
Insider filings
36 filings between Nov 18, 2025 and Aug 26, 2026.
Open market
decisions to buy or sellPurchases
$38.2K
1 purchase by 1 insider
Sales
$329.5K
1 sale by 1 insider
100% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 19
- Award — granted as compensation
- 15
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| McCarthy Daniel Joseph | — | $329.5K | Aug 26, 2026 |
| Springstubb Brendan B | $38.2K | — | Nov 18, 2025 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 26, 2026 | McCarthy Daniel Joseph PRESIDENT | Sale 10b5-1 plan | 65,892 | $329.5K |
| Jul 1, 2026 | Blackley Seth Chief Executive Officer | Tax withheld | 10,297 | $59.1K |
| Jul 1, 2026 | Weinberg Jonathan General Counsel | Tax withheld | 2,650 | $15.2K |
| Jul 1, 2026 | Weinberg Jonathan General Counsel | Award | 43,055 | $0 |
| Jul 1, 2026 | Blackley Seth Chief Executive Officer | Award | 446,102 | $0 |
| Jul 1, 2026 | Shams Aammaad Chief Accounting Officer | Award | 28,790 | $0 |
| Jul 1, 2026 | McCarthy Daniel Joseph PRESIDENT | Tax withheld | 4,582 | $26.3K |
| Jul 1, 2026 | McCarthy Daniel Joseph PRESIDENT | Award | 302,585 | $0 |
| Jun 4, 2026 | Ajayi Toyin Director | Award | 41,096 | $0 |
| Jun 4, 2026 | Smith Jill D. Director | Award | 41,096 | $0 |
| Jun 4, 2026 | GRUA PETER J Director | Award | 41,096 | $0 |
| Jun 4, 2026 | Barbarosh Craig A. Director | Award | 41,096 | $0 |
| Jun 4, 2026 | Springstubb Brendan B Director | Award | 41,096 | $0 |
| Jun 4, 2026 | KECK KIM Director | Award | 41,096 | $0 |
| Jun 4, 2026 | Jelinek Richard M Director | Award | 41,096 | $0 |
| Jun 4, 2026 | GUERTIN SHAWN M Director | Award | 41,096 | $0 |
| Jun 4, 2026 | Glass Russell Monroe Director | Award | 41,096 | $0 |
| Mar 3, 2026 | Blackley Seth Chief Executive Officer | Tax withheld | 24,053 | $84.4K |
| Mar 3, 2026 | McCarthy Daniel Joseph PRESIDENT | Tax withheld | 24,027 | $84.3K |
| Mar 3, 2026 | Shams Aammaad Chief Accounting Officer | Tax withheld | 4,311 | $15.1K |
| Mar 3, 2026 | Weinberg Jonathan General Counsel | Tax withheld | 8,275 | $29.0K |
| Mar 2, 2026 | Weinberg Jonathan General Counsel | Tax withheld | 1,896 | $6.8K |
| Mar 2, 2026 | Shams Aammaad Chief Accounting Officer | Award | 1,686 | $0 |
| Mar 2, 2026 | Shams Aammaad Chief Accounting Officer | Tax withheld | 850 | $3.0K |
| Mar 2, 2026 | McCarthy Daniel Joseph PRESIDENT | Award | 39,281 | $0 |
| Mar 2, 2026 | McCarthy Daniel Joseph PRESIDENT | Tax withheld | 18,192 | $65.1K |
| Mar 2, 2026 | Blackley Seth Chief Executive Officer | Award | 58,921 | $0 |
| Mar 2, 2026 | Blackley Seth Chief Executive Officer | Tax withheld | 17,736 | $63.5K |
| Mar 2, 2026 | Weinberg Jonathan General Counsel | Award | 4,910 | $0 |
| Mar 1, 2026 | Shams Aammaad Chief Accounting Officer | Tax withheld | 2,577 | $8.4K |
| Mar 1, 2026 | Blackley Seth Chief Executive Officer | Tax withheld | 9,537 | $31.0K |
| Mar 1, 2026 | McCarthy Daniel Joseph PRESIDENT | Tax withheld | 7,811 | $25.4K |
| Mar 1, 2026 | Weinberg Jonathan General Counsel | Tax withheld | 4,406 | $14.3K |
| Jan 2, 2026 | Smith Jill D. Director | Award | 23,137 | $0 |
| Jan 2, 2026 | Ramos Mario Chief Financial Officer | Award | 587,500 | $0 |
| Nov 18, 2025 | Springstubb Brendan B Director | Purchase | 10,000 | $38.2K |
| Aug 1, 2025 | Shams Aammaad Chief Accounting Officer | Tax withheld | 2,567 | $25.6K |
| Jul 1, 2025 | Johnson John Paul Chief Financial Officer | Award | 25,461 | $0 |
| Jul 1, 2025 | McCarthy Daniel Joseph PRESIDENT | Award | 44,767 | $0 |
| Jul 1, 2025 | Weinberg Jonathan General Counsel | Award | 23,394 | $0 |
| Jul 1, 2025 | Blackley Seth Chief Executive Officer | Award | 67,150 | $0 |
| Jun 5, 2025 | Barbarosh Craig A. Director | Award | 21,979 | $0 |
| Jun 5, 2025 | Ajayi Toyin Director | Award | 21,979 | $0 |
| Jun 5, 2025 | KECK KIM Director | Award | 21,979 | $0 |
| Jun 5, 2025 | GRUA PETER J Director | Award | 21,979 | $0 |
| Jun 5, 2025 | Glass Russell Monroe Director | Award | 21,979 | $0 |
| Jun 5, 2025 | Springstubb Brendan B Director | Award | 21,979 | $0 |
| Jun 5, 2025 | Scott Cheryl Director | Award | 21,979 | $0 |
| Jun 5, 2025 | Jelinek Richard M Director | Award | 21,979 | $0 |
| Jun 5, 2025 | GUERTIN SHAWN M Director | Award | 21,979 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Evolent Health, Inc.
Free account. Everything above stays public.
Write why you follow Evolent Health, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading